Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Cellectis Q1 Adj $(0.14) Beats $(0.33) Estimate, Sales $6.50M Beat $3.70M Estimate

Author: Benzinga Newsdesk | May 28, 2024 04:33pm

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.33) by 57.58 percent. This is a 74.55 percent increase over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $3.70 million by 75.62 percent. This is a 82.58 percent increase over sales of $3.56 million the same period last year.

Posted In: CLLS